Tropical Medicine Institute Pedro Kourí, Autopista Novia del Mediodía Km 6½, La Lisa, Ciudad de La Habana, 17100, Cuba.
Int J Infect Dis. 2013 Jul;17(7):e565-7. doi: 10.1016/j.ijid.2013.01.028. Epub 2013 Mar 25.
The influenza A(H1N1)pdm09 virus was detected in Cuba in May 2009. The introduction of a new virus with increased transmissibility into a population makes surveillance of the pandemic strain to the molecular level necessary. The aim of the present study was the molecular and phylogenetic analysis of pandemic influenza A(H1N1)pdm09 strains that circulated in Cuba between May 2009 and August 2010. Seventy clinical samples were included in the study. Nucleotide sequences from the hemagglutinin HA1 region segment were obtained directly from clinical samples. Genetic distances were calculated using MEGA v.5.05. A phylogenetic tree was constructed using MrBayes v.3.1.2 software. Potential N-glycosylation sites were predicted using NetNGlyc server 1.0. The 48 Cuban sequences of influenza A(H1N1)pdm09 obtained were similar to the A/California/07/2009 (H1N1) vaccine strain. Most of the Cuban strains belonged to clade 7. Cuban viruses showed amino acid changes, some of them located at three antigenic sites: Ca, Sa, and Sb. Two dominant mutations were detected: P83S (100%) and S203T (85.7%). Glycosylation site analysis revealed the gain of one site at position 162 in 13 sequences. The findings in this study contribute to our understanding of the progress of the influenza A(H1N1)pdm09 virus, since this virus is at the starting point of its evolution in humans.
2009 年 5 月在古巴检测到甲型 H1N1pdm09 病毒。一种具有更高传染性的新病毒传入人群,使得对大流行株进行分子水平的监测成为必要。本研究的目的是对 2009 年 5 月至 2010 年 8 月在古巴流行的甲型 H1N1pdm09 流感大流行株进行分子和系统发育分析。本研究纳入了 70 份临床样本。血凝素(HA1)区的核苷酸序列直接从临床样本中获得。遗传距离使用 MEGA v.5.05 计算。使用 MrBayes v.3.1.2 软件构建系统发育树。使用 NetNGlyc 服务器 1.0 预测潜在的 N-糖基化位点。获得的 48 株古巴甲型 H1N1pdm09 序列与 A/California/07/2009(H1N1)疫苗株相似。大多数古巴株属于 7 类。古巴病毒显示氨基酸变化,其中一些位于 3 个抗原位点:Ca、Sa 和 Sb。检测到两种主要突变:P83S(100%)和 S203T(85.7%)。糖基化位点分析显示 13 个序列在位置 162 获得一个位点。本研究的发现有助于我们了解甲型 H1N1pdm09 病毒的进展,因为这种病毒正处于其在人类中进化的起点。